Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
07/2003
07/08/2003US6589752 Recombinant antigen of Taenia solium metacestodes
07/08/2003US6589750 Therapeutic use of the SMR1 protein, the SMR1 maturation products, specifically the QHNPR pentapeptide as well as its biologically active derivatives
07/08/2003US6589745 CIF130 inhibits cell cycle progression
07/08/2003US6589738 Expressing a sublethal level of an antisense nucleic acid complementary to a nucleic acid encoding said gene to reduce its activity; drug screening; antibiotics
07/08/2003US6589534 Hepatitis B virus binding proteins and uses thereof
07/08/2003US6589533 Able to span or correctly integrate into cell membrane of insects but not mammals
07/08/2003US6589532 Papilloma viruses, means for the detection thereof and therapy for diseases caused thereby
07/08/2003US6589530 Hepatitis B surface antigen vaccine
07/08/2003US6589529 Recombinant fusion proteins as immunogens; VP6 protein or carboxy- terminal fragment
07/08/2003US6589523 Agent for gene therapy of dilated cardiomyopathy
07/08/2003US6589522 Vaccines against infections caused by YF virus; YF infectious cDNA, method for producing a recombinant YF virus from the YF infectious cDNA and plasmids to assemble the YF infectious cDNA
07/08/2003US6589505 Cells that lack p19ink4d and p27kip1 activity and methods of use thereof
07/08/2003US6589503 Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy
07/08/2003US6589326 Coating fluid for imaging element comprising solubilized collagen gelatin and hardener
07/08/2003CA2141203C Amylin muteins
07/08/2003CA2133646C Stem cell proliferation factor
07/08/2003CA2080920C Cloning by complementation and related processes
07/08/2003CA2035384C Preparation and use of gene banks of synthetic human antibodies ("synthetic human-antibody libraries")
07/03/2003WO2003054755A2 Vaccine for periodontal disease
07/03/2003WO2003054543A2 Probe for mass spectrometry
07/03/2003WO2003054542A1 Novel g-protein coupled receptors
07/03/2003WO2003054540A1 Dna encoding a human receptor (hp15a) and uses thereof
07/03/2003WO2003054219A2 Nucleic acid-associated proteins
07/03/2003WO2003054215A2 Therapeutic protein and nucleic acid
07/03/2003WO2003054213A2 NON-HUMAN PRIMATE Fc RECEPTORS AND METHODS OF USE
07/03/2003WO2003054211A2 Receptors for hypersensitive response elicitors and uses thereof
07/03/2003WO2003054207A2 Fermentation process for the preparation of l-amino acids using coryneform bacteria
07/03/2003WO2003054201A1 Method for the transformation of vegetable plastids
07/03/2003WO2003054197A2 A library of modified structural genes or capsid modified particles useful for the identification of viral clones with desired cell tropism
07/03/2003WO2003054196A1 Chitin oligosaccharide elicitor and gibberellin responsive genes in plant and utilization thereof
07/03/2003WO2003054195A1 Novel gene useful in diagnosing cancer and use thereof
07/03/2003WO2003054194A2 Modified tridegins, production and use thereof as transglutaminase inhibitors
07/03/2003WO2003054193A2 Raf/ras binding compounds
07/03/2003WO2003054192A1 Method of identifying gibberellin responsive gene using cultured vegetable cells
07/03/2003WO2003054191A1 Fluorescent proteins
07/03/2003WO2003054190A1 Novel proteins and dnas thereof
07/03/2003WO2003054188A2 Seminal vesicle tissue-specific promoters and uses thereof
07/03/2003WO2003054179A1 Alleles of the siga gene from coryneform bacteria
07/03/2003WO2003054172A2 Glutamine-auxothrophic human cells capable of producing proteins and capable of growing in a glutamine-free medium
07/03/2003WO2003054170A1 Compositions for the in vitro derivation and culture of embryonic stem (es) cell lines with germline transmission capability and for the culture of adult stem cells
07/03/2003WO2003054169A1 Compositions for the in vitro derivation and culture of embryonic stem (es) cell lines with germline transmission capability
07/03/2003WO2003054167A2 Identification of novel polymorphic sites in the human mglur8 gene and uses thereof
07/03/2003WO2003054165A2 Genetic markers and methods for the diagnosis, treatment and prevention of tumor metastasis
07/03/2003WO2003054164A2 C-type lectin polypeptide, polynucleotide and methods of making and use thereof
07/03/2003WO2003054160A2 Cell lines with latent immunodeficiency virus and methods of use thereof
07/03/2003WO2003054158A2 Rapidly maturing fluorescent proteins and methods for using the same
07/03/2003WO2003054156A2 Novel g proein-coupled receptor, gave7
07/03/2003WO2003054152A2 Novel nucleic acids and polypeptides
07/03/2003WO2003054148A2 Zinc finger-based drug-dependent gene regulation system
07/03/2003WO2003054147A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
07/03/2003WO2003054144A2 Human ras interacting protein
07/03/2003WO2003054142A2 Novel sulfurylase-luciferase fusion proteins and thermostable sulfurylase
07/03/2003WO2003054141A2 Sperm-specific cation channel, catsper2, and uses therefor
07/03/2003WO2003054140A2 Phosphate limited inducible promoter and a bacillus expression system
07/03/2003WO2003054019A2 Therapeutic monoclonal anti-tirc7 antibodies for use in immune related and other diseases
07/03/2003WO2003054017A2 Mono-and dual chemokine/cytokine constructs
07/03/2003WO2003054015A2 Use of coagulant-active antitrhombin iii for the therapy of angiogenesis-dependent diseases
07/03/2003WO2003054014A2 Apolipoprotein biopolymer markers predictive of alzheimers disease
07/03/2003WO2003054012A2 Leptin proteins
07/03/2003WO2003054011A2 Polymorphisms of the octn1 and octn2 cation transporters associated with inflammatory bowel disease
07/03/2003WO2003054010A2 Early stage redox-related apoptosis modulator-2 (esram-2)
07/03/2003WO2003054009A2 Apoptotically active peptides
07/03/2003WO2003054008A2 Mammalian simp protein, gene sequence and uses thereof in cancer therapy
07/03/2003WO2003054007A2 Streptococcus antigens
07/03/2003WO2003054006A2 Mutated hiv tat
07/03/2003WO2003054005A2 Bone polypeptide-1
07/03/2003WO2003054004A2 Secreted proteins
07/03/2003WO2003054003A2 Human tid isoforms associated with pathophysiological processes
07/03/2003WO2003054002A1 Peptides for the treatment of cancer associated with the human papilloma virus (hpv) and other epithelial tumours
07/03/2003WO2003053997A2 Methods of increasing endogenous erythropoietin (epo)
07/03/2003WO2003053996A2 Modular peptide-based reagent
07/03/2003WO2003053921A2 Mutant proteinase inhibitors and uses thereof
07/03/2003WO2003053476A1 Adeno-associated virus-mediated delivery of gdnf to skeletal muscles
07/03/2003WO2003053467A1 Drug for regenerating tissue and vessel and method therefor
07/03/2003WO2003053460A1 Crystalline compositions for controlling blood glucose
07/03/2003WO2003053458A1 Use of a pharmaceutical composition containing epidermal growth factor (egf) for diabetic foot amputation prevention
07/03/2003WO2003053457A1 Polypeptide, the conjugate thereof containing doxorubicine and a pharmaceutical composition based thereon
07/03/2003WO2003053364A2 Methods and compositions in treating pain and painful disorders using 1465,1587, 2146, 2207, 32838, 336 and 52908
07/03/2003WO2003053362A2 Systems and methods for treating patients with collagen-rich material extracted from adipose tissue
07/03/2003WO2003053351A2 A NOVEL REGULATORY ELEMENT WITHIN THE IL-Iα PROMOTER AND USES THEREOF
07/03/2003WO2003053339A2 Insulin molecule having protracted time action
07/03/2003WO2003053338A2 Novel chimeric rev, tat, and nef antigens
07/03/2003WO2003053334A2 Compositions and methods for the diagnosis and treatment of tumor
07/03/2003WO2003053332A2 Composition and method for treating viral infection
07/03/2003WO2003053224A2 Novel compositions and methods for cancer
07/03/2003WO2003053220A2 Compositions and methods for the therapy and diagnosis of inflammatory bowel disease
07/03/2003WO2003053158A2 Malleable protein matrix and uses thereof
07/03/2003WO2003053157A1 Enhanced oil seed protein recovery
07/03/2003WO2003053136A2 Triple transgenic mouse model of alzheimer's disease
07/03/2003WO2003053135A1 Plant xrcc3 genes and methods of use
07/03/2003WO2003035881A3 Stress tolerant plants
07/03/2003WO2003033536A3 G-protein coupled receptor
07/03/2003WO2003031590A3 Nucleic acids encoding linked chromo/fluorescent domains and methods for using the same
07/03/2003WO2003031461A3 N-formyl peptide receptor mediation of platelet chemotaxis toward injured cells and activation of immune response
07/03/2003WO2003029488A3 A method for the early detection of cancer
07/03/2003WO2003028666A3 Isolated polypeptides and compositions from the venom of p. transvaalicus and methods of use
07/03/2003WO2003025187A8 Improvement of gene expression in vectors
07/03/2003WO2003025016A3 Trk polypeptide purification method
07/03/2003WO2003016499A3 Combinatorial methods for inducing cancer cell death
07/03/2003WO2003013229A3 An animal model for parkinson's disease
1 ... 1575 1576 1577 1578 1579 1580 1581 1582 1583 1584 1585 1586 1587 1588 1589 1590 1591 1592 1593 1594 1595 ... 2916